<DOC>
	<DOCNO>NCT01324401</DOCNO>
	<brief_summary>Peanut allergy one serious food allergy life long persistence , potential severe allergic reaction . Effective oral immunotherapy would benefit patient reduce likelihood life-threatening accidental allergic reaction . This research study do develop effective oral immunotherapy treatment patient peanut allergy .</brief_summary>
	<brief_title>Oral Peanut Immunotherapy</brief_title>
	<detailed_description>Our hypothesis chronic antigen exposure peanut oral immunotherapy ( OIT ) induce beneficial change specific immune response , include : 1 ) anergy IgE effector immune cell ( e.g. , mast cell , basophil ) result clinical desensitization ; 2 ) induction de novo , long live ( memory ) B cell response antagonize specific IgE confer immune tolerance . The investigator test hypothesis follow specific aim : 1 . Induce desensitization peanut allergic subject peanut OIT evaluate safety peanut OIT desensitization protocol . 2 . Induce long-standing tolerance peanut allergic subject maintenance peanut OIT evaluate efficacy allergen-specific test predict tolerance . 3 . Longitudinally evaluate basophil mast cell reactivity subject receive peanut OIT relationship induction desensitization . 4 . Longitudinally evaluate allergen-specific B-cell repertoire subject receive peanut OIT relationship induction tolerance .</detailed_description>
	<mesh_term>Peanut Hypersensitivity</mesh_term>
	<criteria>Inclusion criterion : 1 . Diagnosis peanut allergy positive prick skin test peanut ( &gt; 8 mm reaction wheal ) CAP FEIA &gt; 10 history objective clinical symptom within one hour ingestion peanuts 2 . Ability provide inform consent . 3 . Males females ethnic/racial group 7 21 year otherwise healthy . Exclusion criterion : 1 . Clinical history severe anaphylactic reaction know suspect caused ingestion peanut require treatment 2 administration epinephrine hospitalization 2 . Moderate Severe Asthma define use Impairment Risk Criteria current NHBLI Guidelines Diagnosis Management Asthma ( http : //www.nhlbi.nih.gov/guidelines/asthma/ ) 3 . Poorly control Asthma define use Control Criteria current NHBLI Guidelines Diagnosis Management Asthma ( http : //www.nhlbi.nih.gov/guidelines/asthma/ ) 4 . Diagnosis severe complicate medical problem 5 . Autoimmune chronic immune gastrointestinal inflammatory condition , include Celiac Disease , Inflammatory Bowel Disease Eosinophilic Gastrointestinal Disorders 6 . Primary Immune Deficiency 7 . Use beta blocker , angiotension convert enzyme inhibitor , monoamine oxidase inhibitor 8 . Women childbearing potential pregnant , plan become pregnant , breastfeed 9 . Use within past year systemic immunomodulatory treatment , include allergen immunotherapy , use biologics immune target , include Xolair</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Peanut Allergy</keyword>
	<keyword>Peanut Hypersensitivity</keyword>
</DOC>